Neurocrine Biosciences Inc (NBIX)
Financial leverage ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total assets | US$ in thousands | 3,251,400 | 2,848,200 | 2,613,100 | 2,359,800 | 2,368,700 | 2,143,400 | 2,005,700 | 2,144,500 | 2,072,500 | 2,017,300 | 1,956,400 | 1,846,400 | 1,734,700 | 1,502,600 | 1,515,600 | 1,361,900 | 1,306,000 | 1,179,940 | 1,066,860 | 957,723 |
Total stockholders’ equity | US$ in thousands | 2,232,000 | 2,002,100 | 1,853,000 | 1,684,500 | 1,707,800 | 1,544,600 | 1,423,400 | 1,391,100 | 1,374,000 | 1,346,000 | 1,279,200 | 1,205,600 | 1,126,200 | 804,300 | 831,200 | 700,300 | 636,900 | 574,500 | 483,700 | 409,300 |
Financial leverage ratio | 1.46 | 1.42 | 1.41 | 1.40 | 1.39 | 1.39 | 1.41 | 1.54 | 1.51 | 1.50 | 1.53 | 1.53 | 1.54 | 1.87 | 1.82 | 1.94 | 2.05 | 2.05 | 2.21 | 2.34 |
December 31, 2023 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $3,251,400K ÷ $2,232,000K
= 1.46
The financial leverage ratio measures the extent to which a company relies on debt to finance its operations and growth. Neurocrine Biosciences' financial leverage ratio has been relatively stable in recent quarters, ranging from 1.39 to 1.46.
A financial leverage ratio of 1.46 in Q4 2023 indicates that for every dollar of equity, the company has $1.46 of total assets, with the difference financed by debt. This suggests that Neurocrine Biosciences has a moderate level of financial leverage, implying a reasonable level of risk associated with debt.
Overall, the trend in the financial leverage ratio for Neurocrine Biosciences has remained within a relatively narrow range, with a slight increase from 1.39 in Q4 2022 to 1.46 in Q4 2023. This stability indicates that the company has maintained a consistent capital structure in recent quarters. However, it would be beneficial for stakeholders to closely monitor any further changes in the ratio to ensure the company's financial health and ability to service its debt obligations effectively.
Peer comparison
Dec 31, 2023